{"title":"Bacterial \u0026 Aquaculture Pathogens","description":null,"products":[{"product_id":"fm-010aw","title":"Anti-Aeromonas Hydrophila, IgG Fraction, Monoclonal, Clone 6B10\/A5","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 6B10\/A5) obtained by immunizing mice with Aeromonas hydrophila (whole bacterial cells). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1: 4,000 dilution), Western Blot (1: 5,000 dilution) and indirect immunofluorescence (1: 1,000 dilution) assays. Aeromonas hydrophila is a Gram-negative rod-shaped bacterium with a single polar flagella and a facultative anaerobic organism which is found in a variety of aquatic environments worldwide. A. hydrophila is considered an important fish pathogen producing haemorrhagic septicemia and furunculosis, disease known as \"Motile Aeromonas Septicemia\" (MAS) or \"Red-Sore Disease\". Several putative determinants of virulence for fish have been described.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Dooley, J.S.G \u0026amp; Trust, T.J. (1988) J. Bacterol. 170, 499-506.\u003cbr\u003e2. Seshadri, R. et al. (2006) J. Bacterol. 188, 8272-8282.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-010AW_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873170222,"sku":"FM-010AW-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-010aw-100ug.png?v=1788008713"},{"product_id":"fm-011ax","title":"Anti-Aeromonas Sobria, IgG Fraction, Monoclonal, Clone 6A1\/E5","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 6A1\/E5) obtained by immunizing mice with Aeromonas sobria (whole bacterial cells). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody recognizes specifically Aeromonas sobria, it has not cross reactivity with both Aeromonas salmonicida and Aeromonas caviae and can be used in ELISA assay (1: 2,000 dilution) and Western blot (1: 1,000 dilution). Aeromonas sobria is a Gram negative and facultative anaerobic bacterium that occurs ubiquitously in aquatic environments. It can infect a wide range of fish species and it is usually considered secondary or opportunistic bacterium affecting fish are usually stressed, have a weakened immune system or have skin lesions. A. sobria infections can cause tail and fin rot, large ulcers, skin lesions, edema and organ damage in fish. It causes gastrointestinal disorders and wound infections in humans.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS. Some of the liquid in the vial could have evaporated with changes in the final volume. However, the mass of the protein is still inside the vial.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Janda, J.M. \u0026amp; Abbott, S.L. (2010) Clin. Microbiol. Rev. 23, 35-73.\u003cbr\u003e2. Aberoum, A. \u0026amp; Jooyandeh, H. (2010) World J. Fish Marine Sci. 2, 519-523.\u003cbr\u003e3. Li, Y. \u0026amp; Cai, S-H. (2011) Curr. Microbiol. 62, 623-627.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-011AX_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873202990,"sku":"FM-011AX-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-011ax-100ug.png?v=1788008713"},{"product_id":"fm-012az","title":"Anti-Aeromonas Caviae, IgG Fraction, Monoclonal, Clone 2C11\/F9","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 2C11\/F9) obtained by immunizing mice with Aeromonas caviae (whole bacterial cells). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody recognizes specifically Aeromonas caviae, it has not cross reactivity with both Aeromonas salmonicida and Aeromonas sobria and can be used in ELISA assay (1: 2,000 dilution) and Western blot (1: 1,000 dilution). Aeromonas caviae is a Gram negative and facultative anaerobic bacterium that occurs ubiquitously in aquatic environments. It can infect a wide range of fish species and it is usually considered secondary or opportunistic bacterium. Affected fish are usually stressed, have a weakened immune system or have skin lesions. A. caviae is responsible for severe skin lesions in fish and it can cause gastroenteritis in humans.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS. Some of the liquid in the vial could have evaporated with changes in the final volume. However, the mass of the protein is still inside the vial.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Janda, J.M. \u0026amp; Abbott, S.L. (2010) Clin. Microbiol. Rev. 23, 35-73.\u003cbr\u003e2. Řehulka, J. (2002) Acta Vet. BRNO 71, 351-360.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-012AZ_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873235758,"sku":"FM-012AZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-012az-100ug.png?v=1788008709"},{"product_id":"fm-012bz","title":"Anti-Aeromonas Caviae, IgG Fraction, Monoclonal, Clone 3G3\/D8","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 3G3\/D8) obtained by immunizing mice with Aeromonas caviae (whole bacterial cells). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody recognizes Aeromonas caviae and it has cross reactivity with Aeromonas salmonicida and Aeromonas sobria. It can be used in ELISA assay (1: 200 dilution) and Western blot (1: 1,000 dilution). Aeromonas caviae is a Gram negative and facultative anaerobic bacterium that occurs ubiquitously in aquatic environments. It can infect a wide range of fish species and it is usually considered secondary or opportunistic bacterium due to affect fish are usually stressed, have a weakened immune system or have skin lesions. A. caviae is responsible for severe skin lesions in fish and it can cause gastroenteritis in humans.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS. Some of the liquid in the vial could have evaporated with changes in the final volume. However, the mass of the protein is still inside the vial.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Janda, J.M. \u0026amp; Abbott, S.L. (2010) Clin. Microbiol. Rev. 23, 35-73.\u003cbr\u003e2. Řehulka, J. (2002) Acta Vet. BRNO 71, 351-360.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-012BZ_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873268526,"sku":"FM-012BZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-012bz-100ug.png?v=1788008713"},{"product_id":"fm-020ay","title":"Anti-Aeromonas Salmonicida, IgG Fraction, Monoclonal, Clone 1D8\/C1","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 1D8\/C1) obtained by immunizing mice with two Chilean isolates of atypical Aeromonas salmonicida (whole bacterial cells). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody recognizes typical (ATCC 14174) and atypical strains of Aeromonas salmonicida and can be used in ELISA (1: 1,000 dilution), Western Blot (1: 1,000 dilution) and indirect immunofluorescence (1: 500 dilution) assays. A. salmonicida is a Gram-negative, non-motile, rod-shaped and facultative anaerobic bacterium, that is the causative agent of furunculosis in both salmonids and non-salmonids species. This systemic fish disease is characterized by high mortality and morbidity and is a significant cause of economic losses in the aquaculture of trout and salmon. Atypical strains produce ulcer disease and erythrodermatitis that can lead to high mortality.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. O'Brien, D. et al. (1994) App. Environ. Microbiol. 3874-3877.\u003cbr\u003e2. Wiklund, T. \u0026amp; Dalsgaard, I. (1998) Dis. Aquat. Org. 32, 49-69.\u003cbr\u003e3. O'hIci, B. et al. (2000) Dis Aquat. Org. 39, 109-119.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-020AY_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873301294,"sku":"FM-020AY-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-020ay-100ug.png?v=1788008713"},{"product_id":"fm-020bz","title":"Anti-Aeromonas Salmonicida, IgG Fraction, Monoclonal, Clone 3B11\/G5","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 3B11\/G5) obtained by immunizing mice with two Chilean isolates of atypical Aeromonas salmonicida (whole bacterial cells).The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody recognizes typical (ATCC 14174) and atypical strains of Aeromonas salmonicida and can be used in ELISA (1: 4,000 dilution), Western Blot (1: 1,000 dilution) and indirect immunofluorescence (1: 1,000 dilution) assays. A. salmonicida is a Gram-negative, non-motile, rod-shaped and facultative anaerobic bacterium, that is the causative agent of furunculosis in both salmonids and non-salmonids species. This systemic fish disease is characterized by high mortality and morbidity and is a significant cause of economic losses in the aquaculture of trout and salmon. Atypical strains produce ulcer disease and erythrodermatitis that can lead to high mortality.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. O'Brien, D. et al. (1994) App. Environ. Microbiol. 3874-3877.\u003cbr\u003e2. Wiklund, T. \u0026amp; Dalsgaard, I. (1998) Dis. Aquat. Org. 32, 49-69.\u003cbr\u003e3. O'hIci, B. et al. (2000) Dis Aquat. Org. 39, 109-119.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-020BZ_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873366830,"sku":"FM-020BZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-020bz-100ug.png?v=1788008691"},{"product_id":"fm-030az","title":"Anti-Vibrio Ordalii, IgG Fraction, Monoclonal, Clone 4B11\/E9","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 4B11\/E9) obtained by immunizing mice with two Chilean isolates of Vibrio ordalii (whole bacterial cells). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody recognizes specifically V.ordalii and can be used in ELISA (1: 8,000 dilution), Western Blot (1: 2,000 dilution), and indirect immunofluorescence (1: 2,000 dilution) assays. Vibrio ordalii is a Gram-negative, short curve rod-shaped, motile by single polar flagellum and facultative anaerobic bacterium. It is the causative agent of vibriosis which is characterized by the presence of skin lesions, haemorrhaging ulcers, serious leukopenia and a high mortality in salmonid and non-salmonid species.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.5 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Wiik, R. et al. (1995) Int. J. Syst. Bacteriol. 45, 421-428.\u003cbr\u003e2. Bohle. H. et al. (2007) Arch. Med. Vet. 39, 43-52.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-030AZ_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873432366,"sku":"FM-030AZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-030az-100ug.png?v=1788008714"},{"product_id":"fm-040ax","title":"Anti-Vibrio Anguillarum, IgG Fraction, Monoclonal, Clone 4F1\/H2","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 4F1\/H2) obtained by immunizing mice with whole cells of Vibrio anguillarum (ATCC 14181). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1: 4,000 dilution), Western blot (1: 1,000 dilution), and indirect immunofluorescence (1: 2,000 dilution) assays. Vibrio anguillarum is a Gram-negative, curve rod-shaped, motile by a single polar flagellum and facultative anaerobic bacterium. It is the causative agent of vibriosis which is characterized by a terminal haemorrhagic septicemia and is associated with high mortality rates in salmonids and non-salmonids species. Different serovars of V.anguillarum have been described as O1 though O23, serovars O1 and O2 are those most often found in fish diseases.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003c\/strong\u003e\u003cbr\u003e1. Myhr, E. et al. (1991) Appl. Environ. Microbiol. 57, 2750-2757.\u003cbr\u003e2. Tiainen, T. et al. (1995) J. Appl. Bacteriol. 79, 384-392.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-040AX_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873465134,"sku":"FM-040AX-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-040ax-100ug.png?v=1788008713"},{"product_id":"fm-050aw","title":"Anti-Yersinia Ruckeri, IgG Fraction, Monoclonal, Clone 4B12\/F8","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 4B12\/F8) obtained by immunizing mice with five Chilean isolates of Yersinia ruckeri (whole bacterial cells). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1: 4,000 dilution), Western blot (1: 8,000 dilution), and indirect immunofluorescence (1: 1,000 dilution) assays. Y. ruckeri is a Gram-negative, rod-shaped bacterium that shows a variable motility due to the presence of flagella. These flagella are not always observed. Y. ruckeri is the causative agent of enteric redmouth disease (ERM) which is characterized by a chronic or acute enterosepticemia with high morbidity and mortality rates in salmonids and non-salmonids species. Six serovars have been described according to whole-cell serological typing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. García, J.A. et al. (1998) J. Appl. Microbiol. 85, 949-955.\u003cbr\u003e2. Tobback, E. et al. (2007) J. Fish Dis. 30, 257-268.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-050AW_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873497902,"sku":"FM-050AW-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-050aw-100ug.png?v=1788008692"},{"product_id":"fm-050bz","title":"Anti-Yersinia Ruckeri, IgG Fraction, Monoclonal, Clone 4D4\/H1)","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 4D4\/H1) obtained by immunizing mice with five Chilean isolates of Yersinia ruckeri (whole bacterial cells). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1: 8,000 dilution), Western blot (1: 2,000 dilution), and indirect immunofluorescence (1: 1,000 dilution) assays. Y. ruckeri is a Gram-negative, rod-shaped bacterium that shows a variable motility due to the presence of flagella. These flagella are not always observed. Y. ruckeri is the causative agent of enteric redmouth disease (ERM) which is characterized by a chronic or acute enterosepticemia with high morbidity and mortality rates in salmonids and non-salmonids species. Six serovars have been described according to whole-cell serological typing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. García, J.A. et al. (1998) J. Appl. Microbiol. 85, 949-955.\u003cbr\u003e2. Tobback, E. et al. (2007) J. Fish Dis. 30, 257-268.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-050BZ_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873530670,"sku":"FM-050BZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-050bz-100ug.png?v=1788008690"},{"product_id":"fm-050cx","title":"Anti-Yersinia Ruckeri, IgG Fraction, Monoclonal, Clone 7F5\/F6","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 7F5\/F6) obtained by immunizing mice with five Chilean isolates of Yersinia ruckeri (whole bacterial cells). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1: 4,000 dilution), Western blot (1: 8,000 dilution), and indirect immunofluorescence (1: 1,000 dilution) assays. Y. ruckeri is a Gram-negative, rod-shaped bacterium that shows a variable motility due to the presence of flagella. These flagella are not always observed. It is the causative agent of enteric redmouth disease (ERM) which is characterized by a chronic or acute enterosepticemia with high morbidity and mortality rates in salmonids and non-salmonids species. Six serovars have been described according to whole-cell serological typing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. García, J.A. et al. (1998) J. Appl. Microbiol. 85, 949-955.\u003cbr\u003e2. Tobback, E. et al. (2007) J. Fish Dis. 30, 257-268.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-050CX_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873563438,"sku":"FM-050CX-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-050cx-100ug.png?v=1788008713"},{"product_id":"fm-060az","title":"Anti-Flavobacterium Psychrophilum, IgG fraction, Monoclonal, Clone 8E10\/G6","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 8E10\/G6) obtained by immunizing mice with six Chilean isolates of Flavobacterium psychrophilum (whole bacterial cells). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1:1,000 dilution), Western blot (1: 1,000 dilution), and indirect immunofluorescence (1:1,000 dilution) assays. F. psychrophilum is a Gram-negative, slender rod-shaped bacterium with rounded ends that are motile by gliding. It is widespread woldwide and is the causative agent of bacterial cold water disease (CWD) which cause high mortality in salmonid and non-salmonid species.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Crump, E.M. et al. (2001) Appl. Environ. Microbiol. 67, 750-759.\u003cbr\u003e2. Nematollahi, A.D. et al. (2003) J. Fish Dis. 26, 563-574.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-060AZ_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873596206,"sku":"FM-060AZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-060az-100ug.png?v=1788008690"},{"product_id":"fm-070az","title":"Anti-Flavobacterium Columnare, IgG fraction, Monoclonal, Clone 4H10\/F12","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 4H10\/F12) obtained by immunizing mice with a Chilean isolate of Flavobacterium columnare (whole bacterial cells). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1:1,000 dilution) and indirect immunofluorescence (1:1,000 dilution) assays. F.columnare is a yellow-pigmented filamentous Gram-negative bacterium and the causative agent of Columnaris disease, one of the most important bacterial diseases of freshwater fish. Columnaris disease is characterized as an acute to chronic infection of the gills, oropharynx, and skin with a high level of mortality (50-90%) in salmonid and non-salmonid species.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Thomas-Jinu, S. \u0026amp; Goodwin, A E. (2004) J. Fish Dis. 27, 29-35.\u003cbr\u003e2. Welker, T.L. et al. (2005) Dis. Aquat. Org. 63, 129-138.\u003cbr\u003e3. Zhang, Y. et al. (2006) J. Fish Dis. 29, 657-663.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use\"\u003e\n\u003ch3 id=\"ab-published-use-fm-070az\"\u003ePublished product use\u003c\/h3\u003e\n\u003cp\u003eA peer-reviewed study reported use of FM-070AZ-5 for flow-cytometric detection of Flavobacterium covae:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFlow cytometry:\u003c\/strong\u003e FM-070AZ-5 was fluorescein-labeled and used to identify and enumerate F. covae in water samples by flow cytometry. \u003ca href=\"https:\/\/doi.org\/10.3389\/fphys.2022.886480\" rel=\"noopener\" target=\"_blank\"\u003eKaimal et al., Frontiers in Physiology (2022)\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-070AZ_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873628974,"sku":"FM-070AZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-070az-100ug.png?v=1788008690"},{"product_id":"fm-080az","title":"Anti-Renibacterium salmoninarum. IgG fraction monoclonal antibody (clone 6G12\/F12)","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 6G12\/F12) obtained by immunizing mice with whole cells of Renibacterium salmoninarum (ATCC 33209). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1: 1,000 dilution), Western blot (1: 1,000 dilution) and indirect immunofluorescence (1: 1,000). R.salmoninarum is a small Gram-positive, non motile rod bacillus and is an obligate pathogen. It is the causative agent of bacterial kidney disease (BKD), one of the most important bacterial diseases affecting cultured salmonids. BKD can be transmitted horizontally from fish to fish and vertically within the egg. The morbidity rate is high and the mortality is delayed, but may become serious in highly infected populations (40-80%).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e Bruno, D.W. \u0026amp; Munro, A.L.S. (1986) FEMS Microbiol. Lett. 33, 247-250. Grayson, T.H. et al. (1999) App. Environ. Microbiol. 65, 961-968. Bruno, D.W. (2004) Dis. Aquat. Org. 59, 125-130.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-080AZ_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873661742,"sku":"FM-080AZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-080az-100ug.png?v=1788008690"},{"product_id":"fm-090av","title":"Anti-Streptococcus phocae. Monoclonal antibody Ascitic Fluid (clone 5G11\/B6)","description":"\u003cp\u003eMouse monoclonal antibody ascitic fluid (clone 5G11\/B6) obtained by immunizing mice with attenuated whole cells of a Chilean isolate of Streptococcus phocae.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1: 2,000 dilution), Western blot (1: 1,000 dilution) and indirect immunofluorescence (1: 500 dilution). S.phocae is a Gram-positive, non-spore forming, facultative anaerobic cocci. It is the causative agent of an acute disease on fish species characterized by haemorrhages on the skin and different organs and muscle. This disease can lead to high mortality with significant economic losses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e 100 µL ascitic fluid\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e Skaar, I. et al. (1994) Int. J. Syst. Bacteriol. 44, 646-650. Ghittino, C. et al. (2003) Vet. Res. Comm. 27, 471-479. Gibello, A. et al. (2005) J. Clin, Microbiol. 43, 526-527.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873694510,"sku":"FM-090AV-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-090av-100ug.png?v=1788008713"},{"product_id":"fm-120ay","title":"Anti-Infectious Salmon Anemia Virus Nucleoprotein (ISAV), IgG Fraction, Monoclonal, Clone 2C7\/E12","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 2C7\/E12) obtained by immunizing mice with a purified C-terminal ISAV nucleoprotein recombinant fragment (aa161-616). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1:2,000 dilution), Western blot (1:1,000 dilution), immunoprecipitation (1:100 dilution), and indirect immunofluorescence (1:500). It recognizes a 68 kDa protein corresponding to ISAV nucleoprotein. ISAV is an enveloped virus that belongs to the family Orthomyxoviridae and genus Isavirus. Its genoma comprises eight negative-sense, single-stranded RNA segments and encodes four major structural proteins including the matrix, the nucleoprotein, and two membrane glycoproteins (hemagglutinin-esterase and gp50). ISAV infects mainly endothelial cells and leukocytes and causes a multisystemic disease characterized by high mortality with exophthalmia, pale gills, ascites, hemorrhagic liver necrosis, and renal interstitial hemorrhage.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Rimstad, E. \u0026amp; Mjaaland, S. (2002) APMIS 110, 273-282.\u003cbr\u003e2. Falk,K. et al. (2004) J. Virol. 78, 3063-3071.\u003cbr\u003e3. Aspehaug, V. et al. (2004) Virus Res. 106, 51-60.\u003cbr\u003e4. Goic, B. et al. (2008) Virology 379, 55-63.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-120AY_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873727278,"sku":"FM-120AY-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-120ay-100ug.png?v=1788008691"},{"product_id":"fm-121az","title":"Anti-Infectious Salmon Anemia Virus (ISAV), IgG Fraction, Monoclonal, Clone 2C2\/H4","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 2C2\/H4) obtained by immunizing mice with purified ISA virus. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1:2,000 dilution), Western blot (1:1,000 dilution), Immunoprecipitation (1:200) and indirect immunofluorescence (1:2,000). It recognizes a 68 kDa protein corresponding to ISAV nucleoprotein. ISAV is an enveloped virus that belongs to the family Orthomyxoviridae and genus Isavirus. Its genoma comprises eight negative-sense, single-stranded RNA segments and encodes four major structural proteins including the matrix, the nucleoprotein, and two membrane glycoproteins (hemagglutinin-esterase and gp50). ISAV infects mainly endothelial cells and leukocytes and causes a multisystemic disease characterized by high mortality with exophthalmia, pale gills, ascites, hemorrhagic liver necrosis, and renal interstitial hemorrhage.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Rimstad, E. \u0026amp; Mjaaland, S. (2002) APMIS 110, 273-282.\u003cbr\u003e2. Falk,K. et al. (2004) J. Virol. 78, 3063-3071.\u003cbr\u003e3. Aspehaug, V. et al. (2004) Virus Res. 106, 51-60.\u003cbr\u003e4. Goic, B. et al. (2008) Virology 379, 55-63.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-121AZ_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873760046,"sku":"FM-121AZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-121az-100ug.png?v=1788008690"},{"product_id":"fm-122ax","title":"Anti-Infectious Salmon Anemia Virus (ISAV) Hemagglutinin-Esterease Protein, IgG Fraction, Monoclonal, Clone 8D2\/E9","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 8D2\/E9) obtained by immunizing mice with a purified N-terminal hemagglutinin recombinant fragment of ISAV. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1:500 dilution), Western blot (1:1,000 dilution), and indirect immunofluorescence (1:1,000). It recognizes two bands, one at 42 kDa corresponding to ISAV hemagglutinin-esterase and the second at 90 kDa probably corresponding to a dimmer of this protein. ISAV is an enveloped virus that belongs to the family Orthomyxoviridae and genus Isavirus. Its genoma comprises eight negative-sense, single-stranded RNA segments and encodes four major structural proteins including the matrix, the nucleoprotein, and two membrane glycoproteins (hemagglutinin-esterase and gp50). ISAV infects mainly endothelial cells and leukocytes and causes a multisystemic disease characterized by high mortality with exophthalmia, pale gills, ascites, hemorrhagic liver necrosis, and renal interstitial hemorrhage.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003c\/strong\u003e\u003cbr\u003e1. \u003cmeta charset=\"UTF-8\"\u003e\n\u003cspan\u003eKrossøy\u003c\/span\u003e, B. et al. (2001) J. Gen. Virol. 82, 1757-1765.\u003cbr\u003e2. Rimstad, E. \u0026amp; Mjaaland, S. (2002) APMIS 110, 273-282.\u003cbr\u003e3. Falk,K. et al. (2004) J. Virol. 78, 3063-3071.\u003cbr\u003e4. Aspehaug, V. et al. (2004) Virus Res. 106, 51-60.\u003cbr\u003e5. Goic, B. et al. (2008) Virology 379, 55-63.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-122AX_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873792814,"sku":"FM-122AX-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-122ax-100ug.png?v=1788008687"},{"product_id":"fm-123ay","title":"Anti-Infectious Salmon Anemia Virus (ISAV) Fusion Protein, IgG Fraction, Monoclonal, Clone 8B2\/A4","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 8B2\/A4) obtained by immunizing mice with a purified N-terminal fusion ISAV protein recombinant fragment. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1:1,000 dilution), Western blot (1:1,000 dilution), and indirect immunofluorescence (1:500). It recognizes a 50 kDa protein corresponding to ISAV fusion protein. ISAV is an enveloped virus that belongs to the family Orthomyxoviridae and genus Isavirus. Its genoma comprises eight negative-sense, single-stranded RNA segments and encodes four major structural proteins including the matrix, the nucleoprotein, and two membrane glycoproteins (hemagglutinin-esterase and fusion protein gp50). ISAV infects mainly endothelial cells and leukocytes and causes a multisystemic disease characterized by high mortality with exophthalmia, pale gills, ascites, hemorrhagic liver necrosis, and renal interstitial hemorrhage.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Rimstad, E. \u0026amp; Mjaaland, S. (2002) APMIS 110, 273-282.\u003cbr\u003e2. Ritchie, R.J. et al. (2002) Virus Res.84, 161-170.\u003cbr\u003e3. Falk,K. et al. (2004) J. Virol. 78, 3063-3071.\u003cbr\u003e4. Kibenge, F.S. et al. (2007) 4, 34.\u003cbr\u003e5. Goic, B. et al. (2008) Virology 379, 55-63.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-123AY_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873825582,"sku":"FM-123AY-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-123ay-100ug.png?v=1788008680"},{"product_id":"fm-124az","title":"Anti-Infectious Salmon Anemia Virus (ISAV) Matrix Protein, IgG Fraction, Monoclonal, Clone 1D6\/C8","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 1D6\/C8) obtained by immunizing mice with a purified matrix recombinant protein of ISAV. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1:500 dilution), Western blot (1:500 dilution), and indirect immunofluorescence (1:250). It recognizes 23 kDa protein corresponding to ISAV matrix protein. ISAV is an enveloped virus that belongs to the family Orthomyxoviridae and genus Isavirus. Its genoma comprises eight negative-sense, single-stranded RNA segments and encodes four major structural proteins including the matrix, the nucleoprotein, and two membrane glycoproteins (hemagglutinin-esterase and gp50). ISAV infects mainly endothelial cells and leukocytes and causes a multisystemic disease characterized by high mortality with exophthalmia, pale gills, ascites, hemorrhagic liver necrosis, and renal interstitial hemorrhage.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Rimstad, E. \u0026amp; Mjaaland, S. (2002) APMIS 110, 273-282.\u003cbr\u003e2. Ritchie, R.J. et al. (2002) Virus Res.84, 161-170.\u003cbr\u003e3. Falk,K. et al. (2004) J. Virol. 78, 3063-3071.\u003cbr\u003e4. Kibenge, F.S. et al. (2007) 4, 34.\u003cbr\u003e5. Goic, B. et al. (2008) Virology 379, 55-63.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-124AZ_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873858350,"sku":"FM-124AZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-124az-100ug.png?v=1788008686"},{"product_id":"fm-130ay","title":"Anti-Infectious Pancreatic Necrosis Virus (IPNV), IgG Fraction, Monoclonal, Clone 2F9\/F1","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 2F9\/F1) obtained by immunizing mice with purified IPN virus. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody is able to neutralize IPN virus and can be used in ELISA (1:5,000 dilution), Western blot (1:1,000 dilution), and indirect immunofluorescence (1:500). IPNV is a single-shelled, non-enveloped virus that belongs to the family Birnaviridae. Its genoma comprises a bisegmented double-stranded RNA, the segment B encodes VP1 and the segment A yields a polyprotein, pVP2-VP4-VP3 and a small protein (VP5) dispensable for viral replication. The polyprotein is autocatalytically cleaved by the endoprotease VP4 to release the structural proteins pVP2 (62 kDa) and VP3. pVP2 is processed during virus maturation into VP2 (54 kDa) constituting the outer capsid component. IPNV is responsible for infectious pancreatic necrosis, a contagious fish disease characterized by severe damage to the internal organs and tissues with a high mortality among salmonids.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Roberts, R. J. \u0026amp; Pearson MD. (2005) J. Fish Dis. 28, 383-390.\u003cbr\u003e2. Galloux, M. et al. (2004) J. Gen. Virol. 85, 2231-2236.\u003cbr\u003e3. Rodriguez Saint-Jean S. et al. (2003) 62, 113-165.\u003cbr\u003e4. Duncan, R. et al. (1991) Virology 181, 541-552.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use\"\u003e\n\u003ch3 id=\"ab-published-use-fm-130ay\"\u003ePublished product use\u003c\/h3\u003e\n\u003cp\u003eA peer-reviewed study reported use of FM-130AY-5 for infectious pancreatic necrosis virus detection:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSandwich ELISA:\u003c\/strong\u003e FM-130AY-5 was identified as the monoclonal detection antibody in a sandwich ELISA used to identify IPNV. \u003ca href=\"https:\/\/doi.org\/10.3390\/vetsci10010058\" rel=\"noopener\" target=\"_blank\"\u003ePersson et al., Veterinary Sciences (2023)\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-130AY_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873891118,"sku":"FM-130AY-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-130ay-100ug.png?v=1788008679"},{"product_id":"fm-130by","title":"Anti-Infectious Pancreatic Necrosis Virus (IPNV) VP1 Protein, IgG Fraction, Monoclonal, Clone 1A1\/E9","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 1A1\/E9) obtained by immunizing mice with purified IPN virus. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1:5,000 dilution), Western blot (1:1,000 dilution), and indirect immunofluorescence (1:500). It recognizes a 94 kDa protein corresponding to the viral RNA-dependent RNA polymerase (VP1). IPNV is a single-shelled, non-enveloped virus that belongs to the family Birnaviridae. Its genoma comprises a bisegmented double-stranded RNA, the segment B encodes VP1 and the segment A yields a polyprotein, pVP2-VP4-VP3 and a small protein (VP5) dispensable for viral replication. The polyprotein is autocatalytically cleaved by the endoprotease VP4 to release the structural proteins pVP2 and VP3. IPNV is responsible for infectious pancreatic necrosis, a contagious fish disease characterized by severe damage to the internal organs and tissues with a high mortality among salmonids.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Roberts, R. J. \u0026amp; Pearson MD. (2005) J. Fish Dis. 28, 383-390.\u003cbr\u003e2. Rodriguez Saint-Jean S. et al. (2003) 62, 113-165.\u003cbr\u003e3. Duncan, R. et al. (1991) Virology 181, 541-552.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-130BY_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873923886,"sku":"FM-130BY-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-130by-100ug.png?v=1788008679"},{"product_id":"fm-130cy","title":"Anti-Infectious Pancreatic Necrosis Virus (IPNV) VP2 Protein, IgG Fraction, Monoclonal, Clone 1B3\/E10","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 1B3\/E10) obtained by immunizing mice with purified IPN virus. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody is able to neutralize IPN virus and can be used in ELISA (1:5,000 dilution), Western blot (1:1,000 dilution), and indirect immunofluorescence (1:500). It recognizes a 54 kDa protein corresponding to VP2 protein. IPNV is a single-shelled, non-enveloped virus that belongs to the family Birnaviridae. Its genoma comprises a bisegmented double-stranded RNA, the segment B encodes VP1 and the segment A yields a polyprotein, pVP2-VP4-VP3 and a small protein (VP5) dispensable for viral replication. The polyprotein is autocatalytically cleaved by the endoprotease VP4 to release the structural proteins pVP2 (62 kDa) and VP3. pVP2 is processed during virus maturation into VP2 (54 kDa) constituting the outer capsid component. IPNV is responsible for infectious pancreatic necrosis, a contagious fish disease characterized by severe damage to the internal organs and tissues with a high mortality among salmonids.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Roberts, R. J. \u0026amp; Pearson MD. (2005) J. Fish Dis. 28, 383-390.\u003cbr\u003e2. Galloux, M. et al. (2004) J. Gen. Virol. 85, 2231-2236.\u003cbr\u003e3. Rodriguez Saint-Jean S. et al. (2003) 62, 113-165.\u003cbr\u003e4. Duncan, R. et al. (1991) Virology 181, 541-552.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use ab-published-use-complete\"\u003e\n\u003ch3 id=\"ab-published-use-fm-130cy\"\u003ePublications using FM-130CY\u003c\/h3\u003e\n\u003cp\u003eThe following scientific publication report use of this Austral Biologicals product:\u003c\/p\u003e\n\u003col class=\"ab-publication-list ab-publication-list-complete\"\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/s41598-017-03036-w\" rel=\"noopener\" target=\"_blank\"\u003eInfectious pancreatic necrosis virus enters CHSE-214 cells via macropinocytosis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLevican et al., Sci Rep 7(1):3068 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-130CY_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873956654,"sku":"FM-130CY-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-130cy-100ug.png?v=1788008680"},{"product_id":"fm-130dz","title":"Anti-Infectious Pancreatic Necrosis Virus (IPNV) VP3 Protein, IgG Fraction, Monoclonal, Clone 6E1\/F2","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 6E1\/F2) obtained by immunizing mice with purified IPN virus. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1:5,000 dilution), Western blot (1:1,000 dilution), and indirect immunofluorescence (1:500). It recognizes a 31 kDa protein corresponding to the structural VP3 protein. IPNV is a single-shelled, non-enveloped virus that belongs to the family Birnaviridae. Its genoma comprises a bisegmented double-stranded RNA, the segment B encodes VP1 and the segment A yields a polyprotein, pVP2-VP4-VP3 and a small protein (VP5) dispensable for viral replication. The polyprotein is autocatalytically cleaved by the endoprotease VP4 to release the structural proteins VP3 and pVP2. VP3 is an internal protein that interacts with both VP1 and dsRNA in a mutually independent mannner. IPNV is responsible for infectious pancreatic necrosis, a contagious fish disease characterized by severe damage to the internal organs and tissues with a high mortality among salmonids.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.5 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Pedersen, T. et al. (2007) J. Virol. 81, 6652-6663.\u003cbr\u003e2. Roberts, R. J. \u0026amp; Pearson MD. (2005) J. Fish Dis. 28, 383-390.\u003cbr\u003e3. Rodriguez Saint-Jean S. et al. (2003) 62, 113-165.\u003cbr\u003e4. Duncan, R. et al. (1991) Virology 181, 541-552.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-130DZ_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518873989422,"sku":"FM-130DZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-130dz-100ug.png?v=1788008679"},{"product_id":"fm-140ax","title":"Anti-Piscirickettsia Salmonis, IgG Fraction, Monoclonal, Clone 7G4\/D9","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 7G4\/D9) obtained by immunizing mice with purified P. salmonis. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA (1:1,000 dilution), Western blot (1:1,000 dilution), and indirect immunofluorescence (1:500). Piscirickettsia salmonis is a Gram-negative obligate intracellular bacterium found in cytoplasmic vacuoles of infected cells. It is pleiomorphic, predominantly coccoid bacterium that ranges in diameter from 0.5 to 1.5 ?m. P. salmonis belongs to a new family of Piscirickettsiae within the class of ?-proteobacteria and it is the etiological agent of salmonid rickettsial septicaemia (SRS) or piscirickettsiosis. This disease has been identified in salmonids and non salmonids species.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Wilhelm, V. et al. (2006) Vaccine 24, 5083-5091.\u003cbr\u003e2. Fryer, J.L. \u0026amp; Hedrick, R.P. (2003) J. Fish Dis. 26, 251-262.\u003cbr\u003e3. Aguayo, J. et al. (2002) Dis. Aquat. Org. 49, 33-38.\u003cbr\u003e4. Jamett, A. et al. (2001) J. Fish Dis. 24, 205-215.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-140AX_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518874022190,"sku":"FM-140AX-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-140ax-100ug.png?v=1788008669"},{"product_id":"fm-190az","title":"Anti-IgM of Coho salmon (Oncorthynchus kisutch) IgG fraction monoclonal antibody (clone 3H7\/E1)","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 3H7\/E1) obtained by immunizing mice with a purified IgM fraction from Coho salmon (Oncorthynchus kisutch) sera. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA assay (1: 100 dilution) and it has cross reactivity with atlantic salmon (Salmo salar) and rainbow trout (Oncorthynchus myskiss). IgM is the only immunoglobulin class described in salmonids. It circulates throughout the fish body and performs the functions of complement fixation and opsonization. Salmonid IgM is a tetramer characterized by different degree of disulfide polymerization with identical binding sites. The heavy and light chains have a molecular mass of 70 and 25 kDa respectively determined by PAGE-SDS under reducing conditions. The tetramer is 780 kDa determined by gel filtration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS. Some of the liquid in the vial could have evaporated with changes in the final volume. However, the mass of the protein is still inside the vial.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e Sakai, D.K. (1992) Ann. Rev. Fish Dis 2, 223-247.\u003cbr\u003eHåvarstein, L.S. et al. (1990) J. Fish Dis 13, 101-111.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FM-190AZ_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518874054958,"sku":"FM-190AZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fm-190az-100ug.png?v=1788008679"},{"product_id":"fp-100","title":"Rabbit anti-Viral Haemorrhagic Septicemia Virus (VHSV). IgG fraction polyclonal antibody","description":"\u003cp\u003eRabbit polyclonal antibody IgG fraction obtained by immunizing rabbits with three synthetic peptides corresponding to aa168-181 (KTPKTVSVDLYSRK), aa172-283 (TGTEGTRKLTPNK) and aa 308-321 (NMAQRTECLDAHSD) of the VHSV integral glycosylated protein or G protein. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This polyclonal antibody reacts with the mixture of the above peptides in ELISA (1: 200 dilution) and Western blot (1: 1,000 dilution) assays. VHSV belongs to the genus Novirhabdovirus of the family Rhabdoviridae.Its genome consists of a negative single-stranded RNA. The G protein is a type I transmembrane protein localized on the surface of the virus envelope and binds to specific receptors during the infection process. This virus is the causative agent of the viral haemorrhagic septicemia in salmonid and non-salmonid species causing a great economic impact in Europe and North America.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e Benmansour, A. et al. (1997) J. Gen. Virol. 78, 2837-2846. Schülze, H. et al. (1999) Virus Genes 19, 59-65. Einer-Jensen, K. et al. (2004) J. Gen. Virol. 85, 1167-1179.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FP-100_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"1mg","offer_id":52517540888878,"sku":"FP-100-9","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fp-100-1mg.png?v=1788008679"},{"product_id":"fp-110","title":"Rabbit Anti-Infectious Hematopoietic Necrosis Virus (IHNV), IgG Fraction, Polyclonal","description":"\u003cp\u003eRabbit polyclonal antibody IgG fraction obtained by immunizing rabbits with two synthetic peptides corresponding to aa211-219 (DSSQEIKGH) and aa279-290 (KCEDKTVGMRGN) of the IHNV integral glycosylated protein or G protein. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This polyclonal antibody reacts with the mixture of the above peptides in ELISA (1: 200 dilution) and Western blot (1: 1,000 dilution) assays. IHNV belongs to the genus Novirhabdovirus of the family Rhabdoviridae, its genome consists of a negative single-stranded RNA. The G protein is a type I transmembrane protein localized on the surface of the virus envelope and binds to specific receptors during the infection process. IHNV causes acute, systemic disease in salmonid fish characterized by rapid disease progression and high mortality with severe economic impact in North America.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Schülze, H. et al. (1995) J. Gen. Virol. 76, 2519-2527.\u003cbr\u003e2. Troyer, R.M. et al. (2000) J. Gen. Virol. 81, 2823-2832.\u003cbr\u003e3. Ghittino, C. et al.(2003) Vet. Res. Commun. 27, 471-479.\u003cbr\u003e4. Saksida, S.M. (2006) Dis. Aquat. Org. 72, 213-223.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_FP-110_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"1mg","offer_id":52517540954414,"sku":"FP-110-9","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-fp-110-1mg.png?v=1788008679"},{"product_id":"hpa-5000","title":"Helicobacter pylori Cag antigen (RECOMBINANT)","description":"\u003cp\u003eCytotoxin-associated gene A is produced in genetically engineered E. coli. It covers Glu 748 to Glu 1015 of the H. pylori Cag antigen.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 30 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 90% pure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.50 mg\/mL in PBS, 0.1% SDS, 10mM EDTA (pH 7.4)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e 1. Molecular characterization of the 128 kDa immunodominant antigen of H. pylori associated to cytotoxicity and duodenal ulcer. Covacci et al.Proc. Natl. Acad. Sci. USA 90, 5791-5795 (1993).\u003cbr\u003e2. Cloning and expression of a high molecular mass major antigen of H. pylori: Evidence of linkage to cytotoxin production. K. Murali et al. Infection \u0026amp; Immunity 61, 1799-1809 (1993).\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPA-5000_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"50 µg","offer_id":52518878314798,"sku":"HPA-5000-4","price":275.0,"currency_code":"USD","in_stock":true},{"title":"100 µg","offer_id":52518878347566,"sku":"HPA-5000-5","price":495.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpa-5000-50ug.png?v=1788008442"},{"product_id":"hpa-5010","title":"Helicobacter pylori Vac (toxin) antigen (RECOMBINANT)","description":"\u003cp\u003eProtein produced in genetically engineered E. coli cells. It covers from Gly 311 to Ile 819 of the H. pylori vacuolating protein. The aproximatelly MW is 63 kDa.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 63 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 90% pure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.50 mg\/mL in PBS, 0.1% SDS\/ 1mM EDTA 10mM DTT (pH 7.5)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e 1. Purification and characterization of the vacuolating toxin from H. pylori. L.T. Cover and M.J. Blaser J. Biol., Chem. 267, 10570-10575 (1992).\u003cbr\u003e2. Divergence of genetic sequences for the vacuolating citotoxin among H. pylori strains. T.L. Cover et al. J. Biol. Chem. 269, 10566-10573 (1994).\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPA-5010_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"50 µg","offer_id":52518878380334,"sku":"HPA-5010-4","price":295.0,"currency_code":"USD","in_stock":true},{"title":"100 µg","offer_id":52518878413102,"sku":"HPA-5010-5","price":495.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpa-5010-50ug.png?v=1788008490"},{"product_id":"hpa-5020","title":"Helicobacter pylori urease small subunit antigen (RECOMBINANT)","description":"\u003cp\u003eProtein produced in genetically engineered yeast cells. It covers Met 1 to Glu 238.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 27 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 92% pure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.50 mg\/mL in PBS, 0.1% SDS\/10mM EDTA (pH 7.4)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e A. Labigne, V. Cussac and P. Corcoux. Shuttle cloning and nucleotide sequences of H. pylori genes responsible for Urease activity. J. Bacteriol. 173, 1920-1931 (1991).\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPA-5020_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"50 µg","offer_id":52518878445870,"sku":"HPA-5020-4","price":295.0,"currency_code":"USD","in_stock":true},{"title":"100 µg","offer_id":52518878478638,"sku":"HPA-5020-5","price":495.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpa-5020-50ug.png?v=1788008425"},{"product_id":"hpa-5030","title":"Helicobacter pylori urease large subunit antigen (RECOMBINANT)","description":"\u003cp\u003eProtein produced in genetically engineered E. coli cells. It covers Met 1 to LYS559.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 63 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 90% pure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in 50 mM Tris-Cl, 0.1% SDS\/1 mM EDTA (pH 7.5)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e A. Labigne, V. Cussac and P. Corcoux. Shuttle cloning and nucleotide sequences of H. pylori genes responsible for Urease activity. J. Bacteriol. 173, 1920-1931 (1991).\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPA-5030_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"50 µg","offer_id":52518878511406,"sku":"HPA-5030-4","price":295.0,"currency_code":"USD","in_stock":true},{"title":"100 µg","offer_id":52518878544174,"sku":"HPA-5030-5","price":495.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpa-5030-50ug.png?v=1788008421"},{"product_id":"hpa-5040","title":"Helicobacter Pylori Flagellin A Antigen, Recombinant","description":"\u003cp\u003eRecombinant protein produced in genetically engineered E. coli cells. It covers from Met 1 to Thr500.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 50 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 92% pure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.50 mg\/mL in PBS, 0.1% SDS\/1mM EDTA (pH 7.4)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. H. Leying, S. Suerbaum, G. Geis and R. Haas. Cloning and genetic characterization of a H. pylori flagellin gene. Mol. Microbiol. 6, 2863-2874 (1992).\u003cbr\u003e2. Kostzynska, M et al. Identification, characterization, and spatial localization of the flagellin species in Helicobacter pylori flagella. J. Bacteriol. 173 (3), 937-946 (1991).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use ab-published-use-complete\"\u003e\n\u003ch3 id=\"ab-published-use-hpa-5040\"\u003ePublications using HPA-5040\u003c\/h3\u003e\n\u003cp\u003eThe following scientific publications report use of this Austral Biologicals product:\u003c\/p\u003e\n\u003col class=\"ab-publication-list ab-publication-list-complete\"\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1073\/pnas.1417945112\" rel=\"noopener\" target=\"_blank\"\u003eFlagellin-induced NLRC4 phosphorylation primes the inflammasome for activation by NAIP5\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eMatusiak et al., Proc Natl Acad Sci U S A 112(5):1541-1546 (2015).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPA-5040_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"50 µg","offer_id":52518878576942,"sku":"HPA-5040-4","price":295.0,"currency_code":"USD","in_stock":true},{"title":"100 µg","offer_id":52518878609710,"sku":"HPA-5040-5","price":495.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpa-5040-50ug.png?v=1788008426"},{"product_id":"hpm-5001","title":"Anti-Helicobacter Pylori Cag Antigen, IgG Fraction, Monoclonal","description":"\u003cp\u003eIgG fraction from a mouse monoclonal antibody obtained by immunization of highly purified H. pylori Cag antigen (Clone 8C6\/F13).It recognizes the Cag protein in a H. pylori extract.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e Reacts in ELISA and Western blot (1:10,000 - 1:15,000 dilution).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS(pH 7.4)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use ab-published-use-complete\"\u003e\n\u003ch3 id=\"ab-published-use-hpm-5001\"\u003ePublications using Austral Biologicals HPM-5001-5\u003c\/h3\u003e\n\u003cp\u003eThe following scientific publications report use of Austral Biologicals HPM-5001-5:\u003c\/p\u003e\n\u003col class=\"ab-publication-list ab-publication-list-complete\"\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.gastha.2025.100860\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori Exploit Short-Chain Fatty Acids-Induced CAPZA1 Overexpression to Emerge CD44v9-Positive Stemness\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTsugawa et al., Gastro Hep Adv 5(3):100860 (2026).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1186\/s12935-021-02140-2\" rel=\"noopener\" target=\"_blank\"\u003eNF-kB-dependent activation of STAT3 by H. pylori is suppressed by TFF1\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSoutto et al., Cancer Cell Int 21(1):444 (2021).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.15252\/embr.202152878\" rel=\"noopener\" target=\"_blank\"\u003eTIFA has dual functions in Helicobacter pylori-induced classical and alternative NF-κB pathways\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eMaubach et al., EMBO Rep 22(9):e52878 (2021).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/s42003-020-0855-y\" rel=\"noopener\" target=\"_blank\"\u003eCholesteryl α-D-glucoside 6-acyltransferase enhances the adhesion of Helicobacter pylori to gastric epithelium\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eJan et al., Commun Biol 3(1):120 (2020).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/toxins11110618\" rel=\"noopener\" target=\"_blank\"\u003eCagA Effector Protein in Helicobacter pylori -Infected Human Gastric Epithelium in Vivo: From Bacterial Core and Adhesion\/Injection Clusters to Host Cell Proteasome-Rich Cytosol\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., Toxins (Basel) 11(11):E618 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1080\/15548627.2018.1515530\" rel=\"noopener\" target=\"_blank\"\u003eCAPZA1 determines the risk of gastric carcinogenesis by inhibiting Helicobacter pylori CagA-degraded autophagy\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTsugawa et al., Autophagy 15(2):242-258 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/ijms19071826\" rel=\"noopener\" target=\"_blank\"\u003eUnusual Manifestation of Live Staphylococcus saprophyticus, Corynebacterium urinapleomorphum , and Helicobacter pylori in the Gallbladder with Cholecystitis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBackert et al., Int J Mol Sci 19(7):E1826 (2018).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/cdd.2017.89\" rel=\"noopener\" target=\"_blank\"\u003ePathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-κB and caspase-8-dependent apoptotic cell death\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLim et al., Cell Death Differ 24(9):1621-1631 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1039\/c6sc00889e\" rel=\"noopener\" target=\"_blank\"\u003eMetabolic labelling of cholesteryl glucosides in Helicobacter pylori reveals how the uptake of human lipids enhances bacterial virulence\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eJan et al., Chem Sci 7(9):6208-6216 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1004621\" rel=\"noopener\" target=\"_blank\"\u003eA specific A\/T polymorphism in Western tyrosine phosphorylation B-motifs regulates Helicobacter pylori CagA epithelial cell interactions\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eZhang et al., PLoS Pathog 11(2):e1004621 (2015).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0096488\" rel=\"noopener\" target=\"_blank\"\u003eSystematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of Western-type Helicobacter pylori strains\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLind et al., PLoS One 9(5):e96488 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0056291\" rel=\"noopener\" target=\"_blank\"\u003ePresence of terminal EPIYA phosphorylation motifs in Helicobacter pylori CagA contributes to IL-8 secretion, irrespective of the number of repeats\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePapadakos et al., PLoS One 8(2):e56291 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02811.x\" rel=\"noopener\" target=\"_blank\"\u003eCagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSicinschi et al., Clin Microbiol Infect 16(4):369-378 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jcm.02330-08\" rel=\"noopener\" target=\"_blank\"\u003ePolymorphism in the CagA EPIYA motif impacts development of gastric cancer\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eJones et al., J Clin Microbiol 47(4):959-968 (2009).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/iai.00365-08\" rel=\"noopener\" target=\"_blank\"\u003eCholesterol depletion reduces Helicobacter pylori CagA translocation and CagA-induced responses in AGS cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLai et al., Infect Immun 76(7):3293-3303 (2008).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.7326\/0003-4819-140-9-200405040-00028\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori and idiopathic thrombocytopenic purpura\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eFranceschi et al., Annals of Internal Medicine 140(9):766-767 (2004).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/iai.72.2.1043-1056.2004\" rel=\"noopener\" target=\"_blank\"\u003eFunctional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBackert et al., Infect Immun 72(2):1043-1056 (2004).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1086\/368133\" rel=\"noopener\" target=\"_blank\"\u003eIntracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSemino-Mora et al., J Infect Dis 187(8):1165-1177 (2003).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1073\/pnas.96.25.14559\" rel=\"noopener\" target=\"_blank\"\u003eAltered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSegal et al., Proc Natl Acad Sci U S A 96(25):14559-14564 (1999).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPM-5001_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518878642478,"sku":"HPM-5001-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpm-5001-100ug.png?v=1788008425"},{"product_id":"hpm-5011","title":"Anti-Helicobacter Pylori Vac (Toxin) Antigen, IgG Fraction, Monoclonal","description":"\u003cp\u003eMouse monoclonal antibody raised against highly purified H. pylori Vac antigen (Clone 2B8\/F10). It has been purified using protein G.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.25 mg\/mL in 0.1M Tris-HCl (pH 7.5)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use ab-published-use-complete\"\u003e\n\u003ch3 id=\"ab-published-use-hpm-5011\"\u003ePublications using HPM-5011\u003c\/h3\u003e\n\u003cp\u003eThe following scientific publication report use of this Austral Biologicals product:\u003c\/p\u003e\n\u003col class=\"ab-publication-list ab-publication-list-complete\"\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jb.184.22.6155-6162.2002\" rel=\"noopener\" target=\"_blank\"\u003eProteins released by Helicobacter pylori in vitro\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eKim et al., J Bacteriol 184(22):6155-6162 (2002).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPM-5011_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518878675246,"sku":"HPM-5011-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpm-5011-100ug.png?v=1788008425"},{"product_id":"hpm-5021","title":"Anti-Helicobacter Pylori Urease Small Subunit Antigen, IgG Fraction, Monoclonal","description":"\u003cp\u003eMouse monoclonal antibody raised from highly purified H. pylori urease small subunit (Clone 2E4\/F5). It has been purified using protein G.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody may be used on an ELISA or Western blot analysis (1\/100-1\/2500 dilution).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.50 mg\/mL in 0.1M Tris-HCl (pH 7.4)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use ab-published-use-complete\"\u003e\n\u003ch3 id=\"ab-published-use-hpm-5021\"\u003ePublications using HPM-5021\u003c\/h3\u003e\n\u003cp\u003eThe following scientific publications report use of the HPM-5021-5 antibody:\u003c\/p\u003e\n\u003col class=\"ab-publication-list ab-publication-list-complete\"\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1186\/s13099-025-00778-1\" rel=\"noopener\" target=\"_blank\"\u003eExtracts from Plectranthus asirensis and Premna resinosa inhibit Helicobacter pylori-induced epithelial cell damage, DNA double-strand breaks and inflammation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNoman et al., Gut Pathog 17(1):97 (2025).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/iai.70.7.3930-3934.2002\" rel=\"noopener\" target=\"_blank\"\u003eMagnesium uptake by CorA is essential for viability of the gastric pathogen Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePfeiffer et al., Infect Immun 70(7):3930-3934 (2002).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPM-5021_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518878708014,"sku":"HPM-5021-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpm-5021-100ug.png?v=1788008414"},{"product_id":"hpm-5031","title":"Anti-Helicobacter Pylori Urease Large Subunit, IgG Fraction, Monoclonal","description":"\u003cp\u003eIgG fraction from mouse monoclonal antibody (clone 2H5\/D5) obtained by immunization using recombinant H. pylori Urease large subunit (60 kDa). The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable for at least one year. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody can be used in ELISA assays (1: 16,000 dilution) and Western Blot analysis (1: 8,000 dilution). It recognizes the Urease large subunit in an extract of a cytotoxic H. pylori strain.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Opazo, P. (1999) APMIS 107, 1069 – 1078.\u003cbr\u003e2. Müller, I. (2002) Biol. Res. 35, 67 – 84.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use ab-published-use-complete\"\u003e\n\u003ch3 id=\"ab-published-use-hpm-5031\"\u003ePublications using HPM-5031\u003c\/h3\u003e\n\u003cp\u003eThe following scientific publication report use of this Austral Biologicals product:\u003c\/p\u003e\n\u003col class=\"ab-publication-list ab-publication-list-complete\"\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1006464\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori gene silencing in vivo demonstrates urease is essential for chronic infection\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eDebowski et al., PLoS Pathog 13(6):e1006464 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPM-5031_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518878740782,"sku":"HPM-5031-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpm-5031-100ug.png?v=1788008415"},{"product_id":"hpm-5041az","title":"Anti-Helicobacter pylori Flagellin A IgG fraction monoclonal antibody","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 6G5\/F6) obtained by immunizing mice with highly purified recombinant H. pylori flagellin A (FLaA) produced in genetically engineered E.coli cells. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody recognizes specifically recombinant H. pylori FlaA, it does NOT cross react with purified recombinant H. pylori FlaB. It can be used in ELISA assay (1: 200 dilution) and Western blot (1: 4,000 dilution). H. pylori Flagellin is composed of two subunits FlaA (52 kDa) and FlaB (54 kDa), FlaA is the major component of flagellar filaments. Both FlaA and FlaB are responsible for bacterial motility and they are required for bacterial colonization and H. pylori survival in the stomach mucus.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 1.0 mg\/mL in PBS. Some of the liquid in the vial could have evaporated with changes in the final volume. However, the mass of the protein is still inside the vial.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e Opazo, P. et al. (1999) APMIS 107, 1069-1078.\u003cbr\u003eMüller, I. et al. (2002) Biol. Res. 35, 67-84.\u003cbr\u003eKostzynska, M. et al. (1991) J. Bacteriol. 173, 937-946.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPM-5041AZ_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518878773550,"sku":"HPM-5041AZ-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpm-5041az-100ug.png?v=1788008427"},{"product_id":"hpm-5041by","title":"Anti-Helicobacter pylori Flagellin A IgG fraction monoclonal antibody","description":"\u003cp\u003eMouse monoclonal antibody IgG fraction (clone 7G12\/D3) obtained by immunizing mice with highly purified recombinant H. pylori Flagellin A (FLaA) produced in genetically engineered E.coli cells. The IgG fraction was purified using Protein G-Sepharose.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Stable at least one year at -20°C. Avoid repeated freezing and thawing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody recognizes recombinant H. pylori FlaA and it has cross reactivity with purified recombinant H. pylori FlaB. It can be used in ELISA assay (1: 4,000 dilution) and Western blot (1: 2,000 dilution). H. pylori flagellin is composed of two subunits FlaA (52 kDa) and FlaB (54 kDa), FlaA is the major component of flagellar filaments. Both FlaA and FlaB are responsible for bacterial motility and they are required for bacterial colonization and H. pylori survival in the stomach mucus.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.5 mg\/mL in PBS. Some of the liquid in the vial could have evaporated with changes in the final volume. However, the mass of the protein is still inside the vial.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003c\/strong\u003e Opazo, P. et al. (1999) APMIS 107, 1069-1078.\u003cbr\u003eMüller, I. et al. (2002) Biol. Res. 35, 67-84.\u003cbr\u003eKostzynska, M. et al. (1991) J. Bacteriol. 173, 937-946.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPM-5041BY_Datasheet.pdf\" target=\"_blank\" rel=\"noopener\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518878806318,"sku":"HPM-5041BY-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpm-5041by-100ug.png?v=1788008414"},{"product_id":"hpp-5003","title":"Rabbit Anti-Helicobacter Pylori Cag Antigen, IgG Fraction, Polyclonal","description":"\u003cp\u003eIgG fraction obtained from a rabbit immunized with highly purified Cag antigen.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e Reacts in ELISA and Western Blot (1\/5,000 dilution recognizes 100 pg of Cag)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 2.00 mg\/mL (0.5 ml) in 0.1M Tris HCl (pH 7.5)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use ab-published-use-complete\"\u003e\n\u003ch3 id=\"ab-published-use-hpp-5003\"\u003ePublications using Austral Biologicals HPP-5003-9\u003c\/h3\u003e\n\u003cp\u003eThe following scientific publications report use of Austral Biologicals HPP-5003-9:\u003c\/p\u003e\n\u003col class=\"ab-publication-list ab-publication-list-complete\"\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1093\/femsml\/uqaf049\" rel=\"noopener\" target=\"_blank\"\u003eEnhanced ADP-heptose-dependent NF-κB activation by Helicobacter pylori CagA through cortactin-Src-dependent tyrosine phosphorylation of IKKβ\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSharafutdinov et al., Microlife 7:uqaf049 (2026).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1186\/s13099-025-00778-1\" rel=\"noopener\" target=\"_blank\"\u003eExtracts from Plectranthus asirensis and Premna resinosa inhibit Helicobacter pylori-induced epithelial cell damage, DNA double-strand breaks and inflammation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNoman et al., Gut Pathog 17(1):97 (2025).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1186\/s12964-024-01948-5\" rel=\"noopener\" target=\"_blank\"\u003eCultivation and molecular characterization of viable Helicobacter pylori from the root canal of 170 deciduous teeth of children\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eElger et al., Cell Commun Signal 22(1):578 (2024).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.canlet.2024.216939\" rel=\"noopener\" target=\"_blank\"\u003eSOX9 is regulated by AURKA in response to Helicobacter pylori infection via EIF4E-mediated cap-dependent translation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eGomaa et al., Cancer Lett 593:216939 (2024).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.cellin.2024.100161\" rel=\"noopener\" target=\"_blank\"\u003eCortactin-dependent control of Par1b-regulated epithelial cell polarity in Helicobacter infection\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSharafutdinov et al., Cell Insight 3(3):100161 (2024).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1080\/19490976.2023.2263936\" rel=\"noopener\" target=\"_blank\"\u003eTargeting hypoxia-inducible factor-1 alpha suppresses Helicobacter pylori -induced gastric injury via attenuation of both cag -mediated microbial virulence and proinflammatory host responses\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNoto et al., Gut Microbes 15(2):2263936 (2023).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.chom.2023.06.016\" rel=\"noopener\" target=\"_blank\"\u003eA single-nucleotide polymorphism in Helicobacter pylori promotes gastric cancer development\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSharafutdinov et al., Cell Host \u0026amp; Microbe 31(8):1345-1358.e6 (2023).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.celrep.2023.112005\" rel=\"noopener\" target=\"_blank\"\u003eCDK1 bridges NF-κB and β-catenin signaling in response to H. pylori infection in gastric tumorigenesis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eZhu et al., Cell Rep 42(1):112005 (2023).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1010628\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori pathogen inhibits cellular responses to oncogenic stress and apoptosis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePalrasu et al., PLoS Pathog 18(6):e1010628 (2022).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.cellin.2022.100032\" rel=\"noopener\" target=\"_blank\"\u003eEarly and late genome-wide gastric epithelial transcriptome response during infection with the human carcinogen Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSharafutdinov et al., Cell Insight 1(3):100032 (2022).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1007\/s00284-022-02813-9\" rel=\"noopener\" target=\"_blank\"\u003eUnique TLR9 Activation by Helicobacter pylori Depends on the cag T4SS, But Not on VirD2 Relaxases or VirD4 Coupling Proteins\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTegtmeyer et al., Curr Microbiol 79(4):121 (2022).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/ijms23052492\" rel=\"noopener\" target=\"_blank\"\u003eMouse Gastric Epithelial Cells Resist CagA Delivery by the Helicobacter pylori Type IV Secretion System\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eShrestha et al., Int J Mol Sci 23(5):2492 (2022).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1556\/1886.2021.00023\" rel=\"noopener\" target=\"_blank\"\u003eImportance of cortactin for efficient epithelial NF-ĸB activation by Helicobacter pylori, Salmonella enterica and Pseudomonas aeruginosa, but not Campylobacter spp\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTegtmeyer et al., Eur J Microbiol Immunol (Bp) 11(4):95-103 (2022).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1080\/19490976.2022.2105102\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori actively suppresses innate immune nucleic acid receptors\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eDooyema et al., Gut Microbes 14(1):2105102 (2022).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/pathogens11010003\" rel=\"noopener\" target=\"_blank\"\u003eCortactin Promotes Effective AGS Cell Scattering by Helicobacter pylori CagA, but Not Cellular Vacuolization and Apoptosis Induced by the Vacuolating Cytotoxin VacA\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSharafutdinov et al., Pathogens 11(1):3 (2022).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1111\/cmi.13376\" rel=\"noopener\" target=\"_blank\"\u003eThe Helicobacter pylori type IV secretion system upregulates epithelial cortactin expression by a CagA- and JNK-dependent pathway\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSharafutdinov et al., Cellular Microbiology 23(10):e13376 (2021).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/ijms22116045\" rel=\"noopener\" target=\"_blank\"\u003eCortactin Is Required for Efficient FAK, Src and Abl Tyrosine Kinase Activation and Phosphorylation of Helicobacter pylori CagA\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eKnorr et al., Int J Mol Sci 22(11):6045 (2021).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.chom.2021.04.006\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eImai et al., Cell Host \u0026amp; Microbe 29(6):941-958.e10 (2021).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/s41467-021-22317-7\" rel=\"noopener\" target=\"_blank\"\u003eA bacterial small RNA regulates the adaptation of Helicobacter pylori to the host environment\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eKinoshita-Daitoku et al., Nat Commun 12(1):2085 (2021).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.celrep.2020.108159\" rel=\"noopener\" target=\"_blank\"\u003eToll-like Receptor 5 Activation by the CagY Repeat Domains of Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTegtmeyer et al., Cell Reports 32(11):108159 (2020).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.2147\/ott.s230875\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori CagA Protein Attenuates 5-Fu Sensitivity of Gastric Cancer Cells Through Upregulating Cellular Glucose Metabolism\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eGao et al., Onco Targets Ther 13:6339-6349 (2020).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1186\/s13099-020-00363-8\" rel=\"noopener\" target=\"_blank\"\u003eType IV secretion of Helicobacter pylori CagA into oral epithelial cells is prevented by the absence of CEACAM receptor expression\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTegtmeyer et al., Gut Pathog 12:25 (2020).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1172\/jci130015\" rel=\"noopener\" target=\"_blank\"\u003eBacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePalrasu et al., J Clin Invest 130(5):2422-2434 (2020).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1556\/1886.2020.00001\" rel=\"noopener\" target=\"_blank\"\u003eSHP2-Independent Tyrosine Dephosphorylation of Cortactin and Vinculin during Infection with Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eKnorr et al., Eur J Microbiol Immunol (Bp) 10(1):20-27 (2020).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/s42003-020-0855-y\" rel=\"noopener\" target=\"_blank\"\u003eCholesteryl α-D-glucoside 6-acyltransferase enhances the adhesion of Helicobacter pylori to gastric epithelium\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eJan et al., Commun Biol 3(1):120 (2020).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/s41467-019-13506-6\" rel=\"noopener\" target=\"_blank\"\u003eT4SS-dependent TLR5 activation by Helicobacter pylori infection\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePachathundikandi et al., Nat Commun 10(1):5717 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1186\/s12964-019-0481-9\" rel=\"noopener\" target=\"_blank\"\u003eChaperone activity of serine protease HtrA of Helicobacter pylori as a crucial survival factor under stress conditions\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eZarzecka et al., Cell Commun Signal 17(1):161 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/toxins11110618\" rel=\"noopener\" target=\"_blank\"\u003eCagA Effector Protein in Helicobacter pylori -Infected Human Gastric Epithelium in Vivo: From Bacterial Core and Adhesion\/Injection Clusters to Host Cell Proteasome-Rich Cytosol\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., Toxins (Basel) 11(11):E618 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/s41598-019-48030-6\" rel=\"noopener\" target=\"_blank\"\u003eEstablishment of serine protease htrA mutants in Helicobacter pylori is associated with secA mutations\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eZawilak-Pawlik et al., Sci Rep 9(1):11794 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/cancers11081163\" rel=\"noopener\" target=\"_blank\"\u003eTailor-Made Detection of Individual Phosphorylated and Non-Phosphorylated EPIYA-Motifs of Helicobacter pylori Oncoprotein CagA\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePachathundikandi et al., Cancers (Basel) 11(8):E1163 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1111\/febs.14962\" rel=\"noopener\" target=\"_blank\"\u003eSpecific high affinity interaction of Helicobacter pylori CagL with integrin αVβ6 promotes type IV secretion of CagA into human cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBuß et al., FEBS Journal 286(20):3980-3997 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1073\/pnas.1814497116\" rel=\"noopener\" target=\"_blank\"\u003eα-Difluoromethylornithine reduces gastric carcinogenesis by causing mutations in Helicobacter pylori cagY\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSierra et al., Proc Natl Acad Sci U S A 116(11):5077-5085 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1158\/0008-5472.can-18-2651\" rel=\"noopener\" target=\"_blank\"\u003eNod1 Imprints Inflammatory and Carcinogenic Responses toward the Gastric Pathogen Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSuarez et al., Cancer Res 79(7):1600-1611 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/s41598-018-34425-4\" rel=\"noopener\" target=\"_blank\"\u003eEvaluating the origin and virulence of a Helicobacter pylori cagA-positive strain isolated from a non-human primate\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eHashi et al., Sci Rep 8(1):15981 (2018).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.15252\/embj.201798665\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori adhesin HopQ disrupts trans dimerization in human CEACAMs\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eMoonens et al., EMBO J 37(13):e98665 (2018).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0183324\" rel=\"noopener\" target=\"_blank\"\u003eThe Helicobacter pylori type IV secretion system promotes IL-8 synthesis in a model of pediatric airway epithelium via p38 MAP kinase\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eDela et al., PLoS One 12(8):e0183324 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1186\/s13099-017-0189-6\" rel=\"noopener\" target=\"_blank\"\u003eOverexpression of serine protease HtrA enhances disruption of adherens junctions, paracellular transmigration and type IV secretion of CagA by Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eHarrer et al., Gut Pathog 9:40 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1006514\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori modulates host cell responses by CagT4SS-dependent translocation of an intermediate metabolite of LPS inner core heptose biosynthesis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eStein et al., PLoS Pathog 13(7):e1006514 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/mbio.02321-16\" rel=\"noopener\" target=\"_blank\"\u003eFallacy of the Unique Genome: Sequence Diversity within Single Helicobacter pylori Strains\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eDraper et al., mBio 8(1):e02321-16 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/srep38101\" rel=\"noopener\" target=\"_blank\"\u003eSystematic site-directed mutagenesis of the Helicobacter pylori CagL protein of the Cag type IV secretion system identifies novel functional domains\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBönig et al., Sci Rep 6:38101 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1186\/s12866-016-0820-6\" rel=\"noopener\" target=\"_blank\"\u003eSystematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strains\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLind et al., BMC Microbiol 16(1):201 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1039\/c6sc00889e\" rel=\"noopener\" target=\"_blank\"\u003eMetabolic labelling of cholesteryl glucosides in Helicobacter pylori reveals how the uptake of human lipids enhances bacterial virulence\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eJan et al., Chem Sci 7(9):6208-6216 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1111\/hel.12300\" rel=\"noopener\" target=\"_blank\"\u003eEarly Molecular Events in Murine Gastric Epithelial Cells Mediated by Helicobacter pylori CagA\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBanerjee et al., Helicobacter 21(5):395-404 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1111\/mmi.13276\" rel=\"noopener\" target=\"_blank\"\u003eCharacterisation of worldwide Helicobacter pylori strains reveals genetic conservation and essentiality of serine protease HtrA\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTegtmeyer et al., Mol Microbiol 99(5):925-944 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/srep15749\" rel=\"noopener\" target=\"_blank\"\u003eDramatic increase in SHP2 binding activity of Helicobacter pylori Western CagA by EPIYA-C duplication: its implications in gastric carcinogenesis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNagase et al., Sci Rep 5:15749 (2015).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0104611\" rel=\"noopener\" target=\"_blank\"\u003eProteomic characterization of Helicobacter pylori CagA antigen recognized by child serum antibodies and its epitope mapping by peptide array\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eAkada et al., PLOS ONE 9(8):e104611 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/ncomms5423\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori CagA promotes Snail-mediated epithelial-mesenchymal transition by reducing GSK-3 activity\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLee et al., Nature Communications 5:4423 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1007\/s00795-013-0068-2\" rel=\"noopener\" target=\"_blank\"\u003eA new type of intrabacterial nanotransportation system for VacA in Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eWu et al., Medical Molecular Morphology 47(4):224-232 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0071220\" rel=\"noopener\" target=\"_blank\"\u003eElectron microscopic, genetic and protein expression analyses of Helicobacter acinonychis strains from a Bengal tiger\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTegtmeyer et al., PLoS One 8(8):e71220 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1003189\" rel=\"noopener\" target=\"_blank\"\u003eFunctional plasticity in the type IV secretion system of Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBarrozo et al., PLoS Pathog 9(2):e1003189 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0056291\" rel=\"noopener\" target=\"_blank\"\u003ePresence of terminal EPIYA phosphorylation motifs in Helicobacter pylori CagA contributes to IL-8 secretion, irrespective of the number of repeats\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePapadakos et al., PLoS One 8(2):e56291 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.7314\/APJCP.2012.13.12.6305\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori CagA and gastric carcinogenesis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eZheng et al., Asian Pacific Journal of Cancer Prevention 13(12):6305-6310 (2012).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1186\/1757-4749-4-4\" rel=\"noopener\" target=\"_blank\"\u003eDistinct repeat motifs at the C-terminal region of CagA of Helicobacter pylori strains isolated from diseased patients and asymptomatic individuals in West Bengal, India\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eChattopadhyay et al., Gut Pathog 4(1):4 (2012).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3748\/wjg.v18.i5.425\" rel=\"noopener\" target=\"_blank\"\u003eEffect of Helicobacter pylori cdrA on interleukin-8 secretions and nuclear factor kappa B activation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTakeuchi et al., World J Gastroenterol 18(5):425-434 (2012).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0030786\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLee et al., PLoS One 7(2):e30786 (2012).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0021317\" rel=\"noopener\" target=\"_blank\"\u003eProteasome particle-rich structures are widely present in human epithelial neoplasms: correlative light, confocal and electron microscopy study\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., PLoS One 6(6):e21317 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0019614\" rel=\"noopener\" target=\"_blank\"\u003eInduction of TLR-2 and TLR-5 expression by Helicobacter pylori switches cagPAI-dependent signalling leading to the secretion of IL-8 and TNF-α\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eKumar et al., PLoS One 6(5):e19614 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0017510\" rel=\"noopener\" target=\"_blank\"\u003eDifluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBarry et al., PLoS One 6(2):e17510 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1093\/infdis\/jiq090\" rel=\"noopener\" target=\"_blank\"\u003eEffects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOhno et al., J Infect Dis 203(5):726-735 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1111\/j.1574-695X.2010.00761.x\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori defines local immune response through interaction with dendritic cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eAndres et al., FEMS Immunology \u0026amp; Medical Microbiology 61(2):168-178 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pgen.1001069\" rel=\"noopener\" target=\"_blank\"\u003eA global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOlbermann et al., PLoS Genet 6(8):e1001069 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1111\/j.1365-2958.2010.07307.x\" rel=\"noopener\" target=\"_blank\"\u003eBiochemical and functional characterization of Helicobacter pylori vesicles\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOlofsson et al., Mol Microbiol 77(6):1539-1555 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1074\/jbc.m110.111054\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2\/ERK and JAK\/STAT signal transduction pathways in gastric epithelial cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLee et al., J Biol Chem 285(21):16042-16050 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0009716\" rel=\"noopener\" target=\"_blank\"\u003eIn vivo accumulation of Helicobacter pylori products, NOD1, ubiquitinated proteins and proteasome in a novel cytoplasmic structure\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., PLOS ONE 5(3):e9716 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/iai.00532-09\" rel=\"noopener\" target=\"_blank\"\u003ePartial protection against Helicobacter pylori in the absence of mast cells in mice\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eDing et al., Infect Immun 77(12):5543-5550 (2009).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jcm.00159-09\" rel=\"noopener\" target=\"_blank\"\u003eCagA and VacA polymorphisms do not correlate with severity of histopathological lesions in Helicobacter pylori-infected Greek children\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSgouras et al., J Clin Microbiol 47(8):2426-2434 (2009).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1086\/596660\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNagy et al., J Infect Dis 199(5):641-651 (2009).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1111\/j.1574-6968.2008.01368.x\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori HopQ outer membrane protein attenuates bacterial adherence to gastric epithelial cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLoh et al., FEMS Microbiol Lett 289(1):53-58 (2008).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1099\/jmm.0.47783-0\" rel=\"noopener\" target=\"_blank\"\u003eAnalysis of Helicobacter pylori isolates from Chile: occurrence of selective type 1 Lewis b antigen expression in lipopolysaccharide\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eAltman et al., Journal of Medical Microbiology 57(Pt 5):585-591 (2008).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/iai.00365-08\" rel=\"noopener\" target=\"_blank\"\u003eCholesterol depletion reduces Helicobacter pylori CagA translocation and CagA-induced responses in AGS cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLai et al., Infect Immun 76(7):3293-3303 (2008).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/mcb.26.1.261-276.2006\" rel=\"noopener\" target=\"_blank\"\u003eFocal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTsutsumi et al., Mol Cell Biol 26(1):261-276 (2006).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/iai.73.8.4643-4652.2005\" rel=\"noopener\" target=\"_blank\"\u003eAnalysis of cell type-specific responses mediated by the type IV secretion system of Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBauer et al., Infect Immun 73(8):4643-4652 (2005).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1073\/pnas.0504927102\" rel=\"noopener\" target=\"_blank\"\u003eActivation of beta-catenin by carcinogenic Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eFranco et al., Proc Natl Acad Sci U S A 102(30):10646-10651 (2005).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1073\/pnas.0409873102\" rel=\"noopener\" target=\"_blank\"\u003eNF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBrandt et al., Proc Natl Acad Sci U S A 102(26):9300-9305 (2005).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jcm.43.2.786-790.2005\" rel=\"noopener\" target=\"_blank\"\u003eTyrosine phosphorylation of CagA from Chinese Helicobacter pylori isolates in AGS gastric epithelial cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eZhang et al., J Clin Microbiol 43(2):786-790 (2005).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jcm.42.6.2508-2517.2004\" rel=\"noopener\" target=\"_blank\"\u003eDistinct diversity of the cag pathogenicity island among Helicobacter pylori strains in Japan\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eAzuma et al., J Clin Microbiol 42(6):2508-2517 (2004).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1074\/jbc.M309964200\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eHigashi et al., Journal of Biological Chemistry 279(17):17205-17216 (2004).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1046\/j.1365-2958.2001.02649.x\" rel=\"noopener\" target=\"_blank\"\u003ePhosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBackert et al., Molecular Microbiology 42(3):631-644 (2001).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/iai.68.5.2863-2869.2000\" rel=\"noopener\" target=\"_blank\"\u003eRole of activated protein C in Helicobacter pylori-associated gastritis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOka et al., Infect Immun 68(5):2863-2869 (2000).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1073\/pnas.96.25.14559\" rel=\"noopener\" target=\"_blank\"\u003eAltered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSegal et al., Proc Natl Acad Sci U S A 96(25):14559-14564 (1999).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPP-5003_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"1mg","offer_id":52517546754350,"sku":"HPP-5003-9","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpp-5003-1mg.png?v=1788008414"},{"product_id":"hpp-5013","title":"Rabbit Anti-Helicobacter Pylori Vac (Toxin) Antigen, IgG Fraction, Polyclonal","description":"\u003cp\u003eRabbit polyclonal antibody raised against highly purified H. pylori Vac antigen. It has been purified using G protein.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody has been used for Western Blot analysis at a 1\/100-1\/2000 dilution.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.70 mg\/mL in 0.1M Tris-HCl (pH 7.5)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use ab-published-use-complete\"\u003e\n\u003ch3 id=\"ab-published-use-hpp-5013\"\u003ePublications using Austral Biologicals HPP-5013-9\u003c\/h3\u003e\n\u003cp\u003eThe following scientific publications report use of Austral Biologicals HPP-5013-9:\u003c\/p\u003e\n\u003col class=\"ab-publication-list ab-publication-list-complete\"\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1186\/s12929-024-01031-8\" rel=\"noopener\" target=\"_blank\"\u003eMembrane lipid remodeling eradicates Helicobacter pylori by manipulating the cholesteryl 6'-acylglucoside biosynthesis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOng et al., J Biomed Sci 31(1):44 (2024).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.micpath.2021.105353\" rel=\"noopener\" target=\"_blank\"\u003eInfection with a hypervirulent strain of Helicobacter pylori primes gastric cells toward intestinal transdifferentiation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSaberi et al., Microbial Pathogenesis 162:105353 (2022).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/ijms22083942\" rel=\"noopener\" target=\"_blank\"\u003eOuter Membrane Vesicle Production by Helicobacter pylori Represents an Approach for the Delivery of Virulence Factors CagA, VacA and UreA into Human Gastric Adenocarcinoma (AGS) Cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eChew et al., Int J Mol Sci 22(8):3942 (2021).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/s41598-017-15204-z\" rel=\"noopener\" target=\"_blank\"\u003eNatural history of Helicobacter pylori VacA toxin in human gastric epithelium in vivo: vacuoles and beyond\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., Sci Rep 7(1):14526 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1007\/s00795-013-0068-2\" rel=\"noopener\" target=\"_blank\"\u003eA new type of intrabacterial nanotransportation system for VacA in Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eWu et al., Medical Molecular Morphology 47(4):224-232 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1177\/039463201302600308\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori HP(2-20) induces eosinophil activation and accumulation in superficial gastric mucosa and stimulates VEGF-alpha and TGF-beta release by interacting with formyl-peptide receptors\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePrevete et al., International Journal of Immunopathology and Pharmacology 26(3):647-662 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3324\/haematol.2011.048462\" rel=\"noopener\" target=\"_blank\"\u003eUbiquitin-proteasome-rich cytoplasmic structures in neutrophils of patients with Shwachman-Diamond syndrome\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., Haematologica 97(7):1057-1063 (2012).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0021317\" rel=\"noopener\" target=\"_blank\"\u003eProteasome particle-rich structures are widely present in human epithelial neoplasms: correlative light, confocal and electron microscopy study\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., PLoS One 6(6):e21317 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1002050\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTan et al., PLoS Pathog 7(5):e1002050 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1093\/infdis\/jiq090\" rel=\"noopener\" target=\"_blank\"\u003eEffects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOhno et al., J Infect Dis 203(5):726-735 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0009716\" rel=\"noopener\" target=\"_blank\"\u003eIn vivo accumulation of Helicobacter pylori products, NOD1, ubiquitinated proteins and proteasome in a novel cytoplasmic structure\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., PLOS ONE 5(3):e9716 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doaj.org\/article\/53dc8d5ea4c14fff9aa933a0fe3cbbc8\" rel=\"noopener\" target=\"_blank\"\u003eCharacterization of the Vacuolating Cytotoxin in Helicobacter pylori Strains Isolated from Iran\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eDouraghi et al., Cell Journal (Yakhteh Medical Journal) 12(1):1-6 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jb.187.13.4463-4469.2005\" rel=\"noopener\" target=\"_blank\"\u003eStable accumulation of sigma54 in Helicobacter pylori requires the novel protein HP0958\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePereira et al., J Bacteriol 187(13):4463-4469 (2005).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/iai.68.5.2863-2869.2000\" rel=\"noopener\" target=\"_blank\"\u003eRole of activated protein C in Helicobacter pylori-associated gastritis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOka et al., Infect Immun 68(5):2863-2869 (2000).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPP-5013_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"1mg","offer_id":52517546852654,"sku":"HPP-5013-9","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpp-5013-1mg.png?v=1788008414"},{"product_id":"vcm-5261","title":"Anti-Vibrio Cholerae 01, IgG Fraction, Monoclonal","description":"\u003cp\u003eMouse IgG anti Vibrio choleral monoclonal antibody reacting with LPS epitopes present in the bacterial cell wall. The antigen used for immunization corresponds to Vibrio cholerae 01, serotype Ogawa, biotype ELT or, inactivated at 56°C for 30 min. This antibody performs well in ELISA, IFI, Western blots and particle aglutination assays. Evaluated through ELISA and indirect immuno-fluorescence (IFI) with two panels of microorganisms normally present in stool samples. One panel include 72 potential antigenically related bacterial strains, the second panel included pathogenic bacterial strains involved in diarrhea cases.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at +4°C. May be frozen at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year +4°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e The antibody reacts with cholera antigens in Western blots.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.25 mg\/mL in 0.1M Tris-HCl (pH 7.5)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Development of highly specific monoclonal antibodies for the diagnosis of Vibrio cholerae 0 (1995) Hybridoma 14(3) 277-278. Castillo L., Castillo D., Silva W., 2. Zapapta L., Reiod M., Ulloa MT., Maldonado A., Valenzuela ME., Bustos R., Tamplin ML., Martinez MA., De Ioannes AE., Jamett A., Yudelevich A., Becker MI.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use\"\u003e\n\u003ch3 id=\"ab-published-use-vcm-5261\"\u003ePublished product use\u003c\/h3\u003e\n\u003cp\u003eA peer-reviewed study reported use of VCM-5261-5 for Vibrio cholerae O1 tissue staining:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eConfocal immunostaining:\u003c\/strong\u003e VCM-5261-5 was used at 2.5 µg\/mL to stain V. cholerae O1 in infected rabbit ileal-loop tissue for scanning confocal microscopy. \u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1001102\" rel=\"noopener\" target=\"_blank\"\u003eNielsen et al., PLOS Pathogens (2010)\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_VCM-5261_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518885523758,"sku":"VCM-5261-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-vcm-5261-100ug.png?v=1788007795"}],"url":"https:\/\/www.australbiologicals.com\/collections\/bacterial-aquaculture-pathogens.oembed?page=2","provider":"Austral Biologicals","version":"1.0","type":"link"}